You are subscribed to the Drug Topics Issue Alert. .

Drug Topics Issue Alert

eNewsletter Subscribe

Print Subscribe

Digital Edition Subscribe

July 19, 2013

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

Check out our July Issue

Treating HIV patients: what’s the pharmacist’s role?

Pharmacists have a relationship with their patients that other healthcare providers do not, and they are in a position to significantly affect disease-state management. » More

Relinquishing oversight of PBMs to the state boards of pharmacy could cause tension

If state pharmacy boards, which are comprised of pharmacists, are in control of PBMs, the boards could act in favor of their own interests. » More

How to address underdosing in obesity

Pharmacists are often confronted with dosing drugs in an obese patient. Unfortunately, many clinical trials exclude or have limited overweight patients enrolled; thus, optimal dosing for both safety and efficacy in this population is lacking. » More

The few words that change everything

Mike Lahr, BS Pharm, PharmD, reflects on his career and the moments that affected him the most. » More

Tennessee pharmacy board strengthens compounding rules

Less than a month after FDA warned of an outbreak following steroid injections from a compounding pharmacy there, the Tennessee Board of Pharmacy strengthened its oversight of compounding pharmacies. » More

 

Downloads

Drug Topics App - Download Drug Topics Digital Edition - Download

You are subscribed to the Drug Topics Issue Alert.

Related Articles

FDA: Ease Avandia restrictions

Target working to improve Medicare Part D Star ratings

Customized targeted messaging builds patient loyalty

HELP Committee passes federal track and trace bill

 
Powered by Modern Medicine Advanstar Medical Communications Group